Literature DB >> 19304586

Agreement between spectral-domain and time-domain OCT for measuring RNFL thickness.

G Vizzeri1, R N Weinreb, A O Gonzalez-Garcia, C Bowd, F A Medeiros, P A Sample, L M Zangwill.   

Abstract

BACKGROUND/AIMS: To evaluate spectral-domain (SD) optical coherence tomography (OCT) reproducibility and assess the agreement between SD-OCT and Time-Domain (TD) OCT retinal nerve fibre layer (RNFL) measurements.
METHODS: Three Cirrus-SD-OCT scans and one Stratus-TD-OCT scan were obtained from Diagnostic Innovations in Glaucoma Study (DIGS) healthy participants and glaucoma patients on the same day. Repeatability was evaluated using Sw (within-subject standard deviation), CV (coefficient of variation) and ICC (intraclass correlation coefficient). Agreement was assessed using correlation and Bland-Altman plots.
RESULTS: 16 healthy participants (32 eyes) and 39 patients (78 eyes) were included. SD-OCT reproducibility was excellent in both groups. The CV and ICC for Average RNFL thickness were 1.5% and 0.96, respectively, in healthy eyes and 1.6% and 0.98, respectively, in patient eyes. Correlations between RNFL parameters were strong, particularly for average RNFL thickness (R(2) = 0.92 in patient eyes). Bland-Altman plots showed good agreement between instruments, with better agreement for average RNFL thickness than for sectoral RNFL parameters (for example, at 90 microm average RNFL thickness, 95% limits of agreement were -13.1 to 0.9 for healthy eyes and -16.2 to -0.3 microm for patient eyes).
CONCLUSIONS: SD-OCT measurements were highly repeatable in healthy and patient eyes. Although the agreement between instruments was good, TD-OCT provided thicker RNFL measurements than SD-OCT. Measurements with these instruments should not be considered interchangeable.

Entities:  

Mesh:

Year:  2009        PMID: 19304586      PMCID: PMC3465953          DOI: 10.1136/bjo.2008.150698

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  32 in total

1.  An optical model of the human retinal nerve fiber layer: implications of directional reflectance for variability of clinical measurements.

Authors:  R W Knighton; C Qian
Journal:  J Glaucoma       Date:  2000-02       Impact factor: 2.503

2.  Statistical analysis of correlated data using generalized estimating equations: an orientation.

Authors:  James A Hanley; Abdissa Negassa; Michael D deB Edwardes; Janet E Forrester
Journal:  Am J Epidemiol       Date:  2003-02-15       Impact factor: 4.897

3.  Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography.

Authors:  Johannes F de Boer; Barry Cense; B Hyle Park; Mark C Pierce; Guillermo J Tearney; Brett E Bouma
Journal:  Opt Lett       Date:  2003-11-01       Impact factor: 3.776

4.  Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT.

Authors:  Lelia A Paunescu; Joel S Schuman; Lori Lyn Price; Paul C Stark; Siobahn Beaton; Hiroshi Ishikawa; Gadi Wollstein; James G Fujimoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

5.  In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography.

Authors:  Nader Nassif; Barry Cense; B Hyle Park; Seok H Yun; Teresa C Chen; Brett E Bouma; Guillermo J Tearney; Johannes F de Boer
Journal:  Opt Lett       Date:  2004-03-01       Impact factor: 3.776

6.  A model for the effect of disturbances in the optical media on the OCT image quality.

Authors:  Pauline H B Kok; Hille W van Dijk; Thomas J T P van den Berg; Frank D Verbraak
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-04       Impact factor: 4.799

7.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

8.  Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography.

Authors:  J S Schuman; T Pedut-Kloizman; E Hertzmark; M R Hee; J R Wilkins; J G Coker; C A Puliafito; J G Fujimoto; E A Swanson
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

9.  Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma.

Authors:  Felipe A Medeiros; Linda M Zangwill; Christopher Bowd; Robert N Weinreb
Journal:  Arch Ophthalmol       Date:  2004-06

10.  Quantitative assessment of structural damage in eyes with localized visual field abnormalities.

Authors:  Harmohina Bagga; David S Greenfield
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

View more
  67 in total

1.  Reproducibility and agreement in evaluating retinal nerve fibre layer thickness between Stratus and Spectralis OCT.

Authors:  S N Arthur; S D Smith; M M Wright; A L Grajewski; Q Wang; J M Terry; M S Lee
Journal:  Eye (Lond)       Date:  2010-11-26       Impact factor: 3.775

2.  Comparison of retinal nerve fiber layer measured by time domain and spectral domain optical coherence tomography in optic neuritis.

Authors:  G Rebolleda; A García-García; H R Won Kim; F J Muñoz-Negrete
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 3.  Imaging of the retinal nerve fibre layer with spectral domain optical coherence tomography for glaucoma diagnosis.

Authors:  Kyung Rim Sung; Jong S Kim; Gadi Wollstein; Lindsey Folio; Michael S Kook; Joel S Schuman
Journal:  Br J Ophthalmol       Date:  2010-10-28       Impact factor: 4.638

4.  Comparison of retinal nerve fiber layer thickness measurement bias and imprecision across three spectral-domain optical coherence tomography devices.

Authors:  Nancy M Buchser; Gadi Wollstein; Hiroshi Ishikawa; Richard A Bilonick; Yun Ling; Lindsey S Folio; Larry Kagemann; Robert J Noecker; Eiyass Albeiruti; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-20       Impact factor: 4.799

5.  Effect of image quality on tissue thickness measurements obtained with spectral domain-optical coherence tomography.

Authors:  Madhusudhanan Balasubramanian; Christopher Bowd; Gianmarco Vizzeri; Robert N Weinreb; Linda M Zangwill
Journal:  Opt Express       Date:  2009-03-02       Impact factor: 3.894

6.  Signal normalization reduces systematic measurement differences between spectral-domain optical coherence tomography devices.

Authors:  Chieh-Li Chen; Hiroshi Ishikawa; Yun Ling; Gadi Wollstein; Richard A Bilonick; Juan Xu; James G Fujimoto; Ian A Sigal; Larry Kagemann; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-05       Impact factor: 4.799

7.  Retinal nerve fiber layer thickness measurement comparability between time domain optical coherence tomography (OCT) and spectral domain OCT.

Authors:  Jong S Kim; Hiroshi Ishikawa; Michelle L Gabriele; Gadi Wollstein; Richard A Bilonick; Larry Kagemann; James G Fujimoto; Joel S Schuman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-08       Impact factor: 4.799

8.  Comparison of measurement error of Cirrus HD-OCT and Heidelberg Retina Tomograph 3 in patients with early glaucomatous visual field defect.

Authors:  Alexander A Shpak; Maria K Sevostyanova; Svetlana N Ogorodnikova; Irina N Shormaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

9.  Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.

Authors:  Byron L Lam; William J Feuer; Joyce C Schiffman; Vittorio Porciatti; Ruth Vandenbroucke; Potyra R Rosa; Giovanni Gregori; John Guy
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

10.  A formula to predict spectral domain optical coherence tomography (OCT) retinal nerve fiber layer measurements based on time domain OCT measurements.

Authors:  Kang Hoon Lee; Min Gu Kang; Hyunsun Lim; Chan Yun Kim; Na Rae Kim
Journal:  Korean J Ophthalmol       Date:  2012-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.